P/E ratio for Aptose Biosciences (APTO)
P/E ratio as of April 2025 (TTM): -0.2212
According to Aptose Biosciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.221228. At the end of 2022 the company had a P/E ratio of -0.0850.
P/E ratio history for Aptose Biosciences from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0850 | -31.02% |
| 2021 | -0.1233 | -71.71% |
| 2020 | -0.4358 | -40.05% |
| 2019 | -0.7269 | 379.54% |
| 2018 | -0.1516 | -45.92% |
| 2017 | -0.2803 | 235.23% |
| 2016 | -0.0836 | -53.54% |
| 2015 | -0.1800 | -48.24% |
| 2014 | -0.3477 | 40.8% |
| 2013 | -0.2469 | 101.16% |
| 2012 | -0.1228 | -64.22% |
| 2011 | -0.3431 | 66.39% |
| 2010 | -0.2062 | -167.06% |
| 2009 | 0.3075 | -989.22% |
| 2008 | -0.0346 | -96.53% |
| 2007 | -0.9956 | 219.39% |
| 2006 | -0.3117 | 83.48% |
| 2005 | -0.1699 | -45.69% |
| 2004 | -0.3128 | -34.44% |
| 2003 | -0.4772 | 43.4% |
| 2002 | -0.3328 | -51.66% |
| 2001 | -0.6884 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | -0.0050 | -97.73% | 🇺🇸 USA |
 | -0.4500 | 103.41% | 🇺🇸 USA |
 | -101 | 45,437.64% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.